BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

356 related articles for article (PubMed ID: 25414825)

  • 1. Ischemic conditioning: the challenge of protecting the diabetic heart.
    Wider J; Przyklenk K
    Cardiovasc Diagn Ther; 2014 Oct; 4(5):383-96. PubMed ID: 25414825
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reduction of myocardial infarct size with ischemic "conditioning": physiologic and technical considerations.
    Przyklenk K
    Anesth Analg; 2013 Oct; 117(4):891-901. PubMed ID: 23960036
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myocardial conditioning: opportunities for clinical translation.
    Ovize M; Thibault H; Przyklenk K
    Circ Res; 2013 Aug; 113(4):439-50. PubMed ID: 23908331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular basis of cardioprotection: signal transduction in ischemic pre-, post-, and remote conditioning.
    Heusch G
    Circ Res; 2015 Feb; 116(4):674-99. PubMed ID: 25677517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Time to Give Up on Cardioprotection? A Critical Appraisal of Clinical Studies on Ischemic Pre-, Post-, and Remote Conditioning.
    Heusch G; Rassaf T
    Circ Res; 2016 Aug; 119(5):676-95. PubMed ID: 27539973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.
    Ferdinandy P; Schulz R; Baxter GF
    Pharmacol Rev; 2007 Dec; 59(4):418-58. PubMed ID: 18048761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of Cardiovascular Nonmodifiable Risk Factors, Comorbidities and Comedications With Ischemia/Reperfusion Injury and Cardioprotection by Pharmacological Treatments and Ischemic Conditioning.
    Ferdinandy P; Andreadou I; Baxter GF; Bøtker HE; Davidson SM; Dobrev D; Gersh BJ; Heusch G; Lecour S; Ruiz-Meana M; Zuurbier CJ; Hausenloy DJ; Schulz R
    Pharmacol Rev; 2023 Jan; 75(1):159-216. PubMed ID: 36753049
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protecting the heart from ischemia/reperfusion injury: an update on remote ischemic preconditioning and postconditioning.
    Donato M; Evelson P; Gelpi RJ
    Curr Opin Cardiol; 2017 Nov; 32(6):784-790. PubMed ID: 28902715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. What is Wrong With Cardiac Conditioning? We May be Shooting at Moving Targets.
    Iliodromitis EK; Cohen MV; Dagres N; Andreadou I; Kremastinos DT; Downey JM
    J Cardiovasc Pharmacol Ther; 2015 Jul; 20(4):357-69. PubMed ID: 25627214
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preconditioning and postconditioning: underlying mechanisms and clinical application.
    Hausenloy DJ; Yellon DM
    Atherosclerosis; 2009 Jun; 204(2):334-41. PubMed ID: 19081095
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ischaemic conditioning: pitfalls on the path to clinical translation.
    Przyklenk K
    Br J Pharmacol; 2015 Apr; 172(8):1961-73. PubMed ID: 25560903
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cGMP-Elevating Compounds and Ischemic Conditioning Provide Cardioprotection Against Ischemia and Reperfusion Injury via Cardiomyocyte-Specific BK Channels.
    Frankenreiter S; Bednarczyk P; Kniess A; Bork NI; Straubinger J; Koprowski P; Wrzosek A; Mohr E; Logan A; Murphy MP; Gawaz M; Krieg T; Szewczyk A; Nikolaev VO; Ruth P; Lukowski R
    Circulation; 2017 Dec; 136(24):2337-2355. PubMed ID: 29051185
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Remote ischemia conditioning-an endogenous cardioprotective strategy from outside the heart.
    Xiong J; Liao X; Xue FS; Yuan YJ; Wang Q; Liu JH
    Chin Med J (Engl); 2011 Jul; 124(14):2209-15. PubMed ID: 21933628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myocardial ischemic conditioning: Physiological aspects and clinical applications in cardiac surgery.
    Bousselmi R; Lebbi MA; Ferjani M
    J Saudi Heart Assoc; 2014 Apr; 26(2):93-100. PubMed ID: 24719539
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Emerging role of non-coding RNAs and extracellular vesicles in cardioprotection by remote ischemic conditioning of the heart.
    Bartekova M; Jelemensky M; Dhalla NS
    Rev Cardiovasc Med; 2019 Jun; 20(2):59-71. PubMed ID: 31344998
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of remote ischemic conditioning in cardiac surgery.
    Bosnjak ZJ; Ge ZD
    F1000Res; 2017; 6():928. PubMed ID: 28690837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional Genomics of Cardioprotection by Ischemic Conditioning and the Influence of Comorbid Conditions: Implications in Target Identification.
    Varga ZV; Giricz Z; Bencsik P; Madonna R; Gyongyosi M; Schulz R; Mayr M; Thum T; Puskas LG; Ferdinandy P
    Curr Drug Targets; 2015; 16(8):904-11. PubMed ID: 25915487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Critical Issues for the Translation of Cardioprotection.
    Heusch G
    Circ Res; 2017 Apr; 120(9):1477-1486. PubMed ID: 28450365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Attenuation of ST-segment elevation after ischemic conditioning maneuvers reflects cardioprotection online.
    Amanakis G; Kleinbongard P; Heusch G; Skyschally A
    Basic Res Cardiol; 2019 Apr; 114(3):22. PubMed ID: 30937537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy of cardioprotective 'conditioning' strategies in aging and diabetic cohorts: the co-morbidity conundrum.
    Przyklenk K
    Drugs Aging; 2011 May; 28(5):331-43. PubMed ID: 21542657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.